CN102427818A - 新用途 - Google Patents

新用途 Download PDF

Info

Publication number
CN102427818A
CN102427818A CN2010800180409A CN201080018040A CN102427818A CN 102427818 A CN102427818 A CN 102427818A CN 2010800180409 A CN2010800180409 A CN 2010800180409A CN 201080018040 A CN201080018040 A CN 201080018040A CN 102427818 A CN102427818 A CN 102427818A
Authority
CN
China
Prior art keywords
gal
galacto
oligosaccharides
glc
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800180409A
Other languages
English (en)
Chinese (zh)
Inventor
G·恰佐尔提斯
J·武莱维奇
F·阿塔纳西奥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clasado Inc
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102427818(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of CN102427818A publication Critical patent/CN102427818A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
CN2010800180409A 2009-04-23 2010-04-23 新用途 Pending CN102427818A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0906983.2 2009-04-23
GBGB0906983.2A GB0906983D0 (en) 2009-04-23 2009-04-23 Novel use
GB0920784.6 2009-11-27
GBGB0920784.6A GB0920784D0 (en) 2009-04-23 2009-11-27 Novel use
PCT/GB2010/050659 WO2010122344A1 (en) 2009-04-23 2010-04-23 Novel use

Publications (1)

Publication Number Publication Date
CN102427818A true CN102427818A (zh) 2012-04-25

Family

ID=40774842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800180409A Pending CN102427818A (zh) 2009-04-23 2010-04-23 新用途

Country Status (25)

Country Link
US (1) US20120058972A1 (enExample)
EP (1) EP2421541B1 (enExample)
JP (1) JP2012524770A (enExample)
KR (1) KR20110138416A (enExample)
CN (1) CN102427818A (enExample)
AU (1) AU2010240642B2 (enExample)
BR (1) BRPI1015091A2 (enExample)
CA (1) CA2759442C (enExample)
CY (1) CY1120597T1 (enExample)
DK (1) DK2421541T3 (enExample)
ES (1) ES2688786T3 (enExample)
GB (3) GB0906983D0 (enExample)
HU (1) HUE040451T2 (enExample)
IL (1) IL215855A0 (enExample)
MX (1) MX341308B (enExample)
MY (1) MY151104A (enExample)
NZ (1) NZ595969A (enExample)
PL (1) PL2421541T3 (enExample)
PT (1) PT2421541T (enExample)
RU (1) RU2530567C2 (enExample)
SG (1) SG175313A1 (enExample)
TR (1) TR201810868T4 (enExample)
UA (1) UA106491C2 (enExample)
WO (1) WO2010122344A1 (enExample)
ZA (1) ZA201107821B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
CN103716787B (zh) 2012-09-29 2020-06-23 北京三星通信技术研究有限公司 一种支持对家用基站进行验证的方法
CA2983236A1 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
BR112021022447A2 (pt) * 2019-05-15 2021-12-28 Nutricia Nv Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1731938A (zh) * 2002-12-12 2006-02-08 诺瓦提斯公司 益生元组合物
CN1777671A (zh) * 2003-06-30 2006-05-24 科拉萨多公司 新的半乳糖寡糖组合物及其制备
WO2010023422A1 (en) * 2008-05-30 2010-03-04 Clasado Inc. Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644482B2 (en) * 2003-06-30 2014-10-01 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1731938A (zh) * 2002-12-12 2006-02-08 诺瓦提斯公司 益生元组合物
CN1777671A (zh) * 2003-06-30 2006-05-24 科拉萨多公司 新的半乳糖寡糖组合物及其制备
WO2010023422A1 (en) * 2008-05-30 2010-03-04 Clasado Inc. Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途

Also Published As

Publication number Publication date
EP2421541A1 (en) 2012-02-29
HUE040451T2 (hu) 2019-03-28
GB2482817B (en) 2014-02-26
KR20110138416A (ko) 2011-12-27
RU2530567C2 (ru) 2014-10-10
NZ595969A (en) 2013-03-28
WO2010122344A1 (en) 2010-10-28
PT2421541T (pt) 2018-10-15
CY1120597T1 (el) 2019-12-11
CA2759442C (en) 2016-01-19
CA2759442A1 (en) 2010-10-28
SG175313A1 (en) 2011-11-28
GB201120030D0 (en) 2012-01-04
TR201810868T4 (tr) 2018-08-27
IL215855A0 (en) 2012-01-31
MY151104A (en) 2014-04-15
EP2421541B1 (en) 2018-07-11
ZA201107821B (en) 2012-07-25
AU2010240642A1 (en) 2011-11-10
PL2421541T3 (pl) 2018-11-30
GB0920784D0 (en) 2010-01-13
AU2010240642B2 (en) 2013-03-14
ES2688786T3 (es) 2018-11-06
GB2482817A (en) 2012-02-15
JP2012524770A (ja) 2012-10-18
MX341308B (es) 2016-08-12
DK2421541T3 (en) 2018-09-24
UA106491C2 (uk) 2014-09-10
BRPI1015091A2 (pt) 2016-04-26
GB0906983D0 (en) 2009-06-03
US20120058972A1 (en) 2012-03-08
RU2011147390A (ru) 2013-05-27
MX2011011159A (es) 2011-11-07

Similar Documents

Publication Publication Date Title
CN102427818A (zh) 新用途
CN102046181A (zh) 益生元低聚半乳糖在治疗肠炎中的应用
JP4384656B2 (ja) 新規のガラクトシダーゼ酵素活性を生じさせるビフィドバクテリウムビフィダムの新規株
US20170000811A1 (en) Prebiotic oligosaccharides
US10912805B2 (en) Extract of algae for use as an immunomodulator agent
US20040235789A1 (en) Isomaltooligosaccharides from Leuconostoc as neutraceuticals
CN102670662A (zh) 糖醛酸和益生菌
JP6612346B2 (ja) 感染症の予防および／または治療のための方法および試薬
KR20180123737A (ko) 박테리아성 히스타민의 산물 및 이의 용도
JP2022513208A (ja) がんを治療するためのｐａｒａｂａｃｔｅｒｏｉｄｅｓ細菌株を含む組成物
KR20190033897A (ko) 클로스트리디움 디피실레(Clostridium difficile) 성장 억제효과를 갖는 클로스트리디움 신덴스 균주
Um et al. Involvement of protein kinase C and tyrosin kinase in tumoricidal activation of macrophage induced by Streptococcus pneumoniae type II capsular polysaccharide
CN101372679B (zh) 一种双歧双歧杆菌菌株及其使用方法
DK2037937T3 (en) TRI AND TETRA-OLIGOSACCHARIDES TO USE AS AGGLUTINATION AGENTS FOR ENTERIC PATHOGENS
朝隈貞樹 et al. Effect of human milk oligosaccharides on messenger ribonucleic acid expression of toll-like receptor 2 and 4, and of MD2 in the intestinal cell line HT-29
Zhao Strain-specific Effects of Bifidobacterium Animalis. Lactis on in Vitro Models of Gastrointestinal Inflammation
WO2021075928A1 (ko) 비피도박테리움 비피덤을 포함하는 면역력 증강 또는 개선용 조성물
Divya et al. Impact Of Human Milk Oligosaccharide (HMO) In Neonates
He et al. W2006 Beneficial Effects of Fermented Milk Containing Lactobacillus GG and L. Gasseri Tmc0356 On Regulating Intestinal Microflora and Immune Responses for Patients with Allergic Disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120425